113 related articles for article (PubMed ID: 20849388)
1. Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified.
Castillo JJ; Morales D; Quinones P; Cotrina E; Desposorio C; Beltran B
Leuk Lymphoma; 2010 Oct; 51(10):1822-8. PubMed ID: 20849388
[TBL] [Abstract][Full Text] [Related]
2. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified.
Beltran BE; Aguilar C; Quiñones P; Morales D; Chavez JC; Sotomayor EM; Castillo JJ
Leuk Lymphoma; 2016; 57(1):58-62. PubMed ID: 25926063
[TBL] [Abstract][Full Text] [Related]
3. Lymphopenia a simple prognostic factor in lymphoma and other cancers: why not use it more as a guide?
Tadmor T; Polliack A
Leuk Lymphoma; 2010 Oct; 51(10):1773-4. PubMed ID: 20849382
[No Abstract] [Full Text] [Related]
4. Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy.
Kim YR; Kim JS; Kim SJ; Jung HA; Kim SJ; Kim WS; Lee HW; Eom HS; Jeong SH; Park JS; Cheong JW; Min YH
J Hematol Oncol; 2011 Aug; 4():34. PubMed ID: 21843362
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects and influencing factors in sixty-eight cases of peripheral T-cell lymphoma unspecified.
Kangsheng G; Di W; Jingjing W
Tumori; 2014; 100(1):21-5. PubMed ID: 24675486
[TBL] [Abstract][Full Text] [Related]
6. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS
Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and prognostic factors of patients with "peripheral T cell lymphoma, unspecified".
Lee Y; Uhm JE; Lee HY; Park MJ; Kim H; Oh SJ; Jang JH; Kim K; Jung CW; Ahn YC; Park K; Ko YH; Kim WS
Ann Hematol; 2009 Feb; 88(2):111-9. PubMed ID: 18648812
[TBL] [Abstract][Full Text] [Related]
8. A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas.
Kaito S; Kanemasa Y; Sasaki Y; Okuya T; Yamaguchi T; Funasaka C; Shimoyama T; Omuro Y; Hishima T; Maeda Y
Int J Hematol; 2018 Apr; 107(4):451-459. PubMed ID: 29103138
[TBL] [Abstract][Full Text] [Related]
9. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.
Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M
Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866
[TBL] [Abstract][Full Text] [Related]
11. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.
Chihara D; Oki Y; Ine S; Yamamoto K; Kato H; Taji H; Kagami Y; Yatabe Y; Nakamura S; Morishima Y
Leuk Lymphoma; 2009 Dec; 50(12):1999-2004. PubMed ID: 19860627
[TBL] [Abstract][Full Text] [Related]
12. Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
Puig N; Wang L; Seshadri T; al-Farsi K; Keating A; Crump M; Kuruvilla J
Leuk Lymphoma; 2013 Mar; 54(3):507-13. PubMed ID: 22897731
[TBL] [Abstract][Full Text] [Related]
13. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.
Ansell SM; Habermann TM; Kurtin PJ; Witzig TE; Chen MG; Li CY; Inwards DJ; Colgan JP
J Clin Oncol; 1997 Jun; 15(6):2296-301. PubMed ID: 9196143
[TBL] [Abstract][Full Text] [Related]
14. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
Vassilakopoulos TP; Dimopoulou MN; Angelopoulou MK; Petevi K; Pangalis GA; Moschogiannis M; Dimou M; Boutsikas G; Kanellopoulos A; Gainaru G; Plata E; Flevari P; Koutsi K; Papageorgiou L; Telonis V; Tsaftaridis P; Sachanas S; Yiakoumis X; Tsirkinidis P; Viniou NA; Siakantaris MP; Variami E; Kyrtsonis MC; Meletis J; Panayiotidis P; Konstantopoulos K
Oncologist; 2016 Mar; 21(3):343-53. PubMed ID: 26921291
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and treatment outcomes of peripheral T-cell lymphoma, unspecified: a report of 78 cases].
Yu YX; Shi YK; He XH; Zhou LQ; Zhou SY; Dong M; Feng FY; Sun Y
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2714-6. PubMed ID: 18167252
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system involvement in T-cell lymphoma: A single center experience.
Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S
Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135
[TBL] [Abstract][Full Text] [Related]
18. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
Pedersen MB; Hamilton-Dutoit SJ; Bendix K; Møller MB; Nørgaard P; Johansen P; Ralfkiaer E; Brown Pde N; Hansen PB; Jensen BA; Madsen J; Schöllkopf C; d'Amore F
Hematol Oncol; 2015 Dec; 33(4):120-8. PubMed ID: 25052551
[TBL] [Abstract][Full Text] [Related]
20. The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.
Rambaldi A; Boschini C; Gritti G; Delaini F; Oldani E; Rossi A; Barbui AM; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Patti C; Gianni AM; Tarella C
Am J Hematol; 2013 Dec; 88(12):1062-7. PubMed ID: 23940056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]